These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3055700)

  • 1. Sex steroid receptors in endometrial cancer.
    Chambers JT
    Yale J Biol Med; 1988; 61(4):339-50. PubMed ID: 3055700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.
    McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS
    Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
    Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
    Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endometrial cancer and steroid hormone receptors].
    Nyholm HC
    Ugeskr Laeger; 1990 Feb; 152(9):593-7. PubMed ID: 2408223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormonal therapy of endometrial cancer].
    Kato J
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1182-8. PubMed ID: 4057575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma.
    Liao BS; Twiggs LB; Leung BS; Yu WC; Potish RA; Prem KA
    Obstet Gynecol; 1986 Apr; 67(4):463-7. PubMed ID: 3960417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid receptors and endometrial cancer.
    Soper JT; Christensen CW
    Clin Obstet Gynaecol; 1986 Dec; 13(4):825-42. PubMed ID: 3539444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and progesterone receptors in uterine sarcomas.
    Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
    Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial cancer: histologic correlates of immunohistochemical localization of progesterone receptor and estrogen receptor.
    Segreti EM; Novotny DB; Soper JT; Mutch DG; Creasman WT; McCarty KS
    Obstet Gynecol; 1989 May; 73(5 Pt 1):780-5. PubMed ID: 2704506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
    Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
    Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic importance of steroid receptors in endometrial carcinoma.
    Palmer DC; Muir IM; Alexander AI; Cauchi M; Bennett RC; Quinn MA
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):388-93. PubMed ID: 3405554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estrogen and progesterone receptors in corpus uteri carcinoma and their clinical significance].
    Kleine W; Fuchs A; deGregorio G; Geyer H
    Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):884-7. PubMed ID: 6925560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between estradiol-17 beta and progesterone cytosol receptor concentration, histologic differentiation and 3H-thymidine incorporation in endometrial carcinoma.
    Lindahl B; Alm P; Borg A; Fernö M; Grundsell H; Johnsson JE; Norgren A; Tropé C
    Anticancer Res; 1982; 2(4):203-7. PubMed ID: 7149649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid hormone receptor content and lymph node status in endometrial cancer.
    Morris PC; Anderson JR; Anderson B; Buller RE
    Gynecol Oncol; 1995 Mar; 56(3):406-11. PubMed ID: 7705676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid receptors in breast cancer.
    Desombre ER
    Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse of endometrial carcinoma related to steroid receptor concentration, staging, histologic grading and myometrial invasion.
    Lindahl B; Alm P; Fernö M; Grundsell H; Norgren A; Tropé C
    Anticancer Res; 1986; 6(6):1317-20. PubMed ID: 3813487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal aspects of endometrial cancer.
    Sutton G
    Curr Opin Obstet Gynecol; 1990 Feb; 2(1):69-73. PubMed ID: 2102309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial and stromal estrogen and progesterone receptor expression in endometrial cancer: true color computer-assisted image analysis versus subjective scoring.
    Kohlberger PD; Kieback DG; Breitenecker F; Loesch A; Gitsch G; Kainz C; Breitenecker G
    Gynecol Oncol; 1997 Mar; 64(3):404-10. PubMed ID: 9062141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma.
    Creasman WT; Soper JT; McCarty KS; McCarty KS; Hinshaw W; Clarke-Pearson DL
    Am J Obstet Gynecol; 1985 Apr; 151(7):922-32. PubMed ID: 3985057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.